NCT01184976View on ClinicalTrials.gov

Study Of VGX-3400, H5N1 Avian Flu Virus Plasmid DNA With Electroporation Device In Healthy Adult Males

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Healthy
Interventions
BIOLOGICAL

VGX-3400

Plasmid DNA delivered via IM injection with electroporation

Trial Locations (2)

120-752

Yonsei University Severance Hospital, Seoul

136-705

Korea University Anam Hospital, Seoul

Sponsors

Collaborators (1)

Inovio Pharmaceuticals
All Listed Sponsors
collaborator

Inovio Pharmaceuticals

INDUSTRY

lead

GeneOne Life Science, Inc.

INDUSTRY

NCT01184976 - Study Of VGX-3400, H5N1 Avian Flu Virus Plasmid DNA With Electroporation Device In Healthy Adult Males | Biotech Hunter | Biotech Hunter